And the winner of this year's Leadership Trip is ......

Quote

Anonymous

Guest
http://www.bnet.com/blog/drug-busin...the-worst-behaved-drug-companies-of-2010/7195

Rogues Gallery: DOJ Lists the Worst-Behaved Drug Companies of 2010
By Jim Edwards | January 25, 2011

Congratulations, Allergan (AGN): The company paid the biggest settlement to the Department of Justice’s healthcare fraud and abuse program in 2010, $600 million for the unapproved, “off-label” promotion of Botox for headaches. 2010 was a banner year for bad behavior in the drug business, according to the DOJ. There were:

o $2.5 billion in health care fraud judgments and settlements.
o 1,116 new criminal health care fraud investigations.
o 2,095 potential defendants in those cases.
o 1,787 ongoing criminal health care fraud investigations pending.
o 2,977 potential defendants in those cases.
o 488 cases with criminal charges filed.
o 931 actual defendants in those cases.
o 726 defendants convicted of health care fraud-related crimes

The statistic that managers ought to pay most attention to is the one describing them. While I’ve criticized the DOJ in the past for talking a lot about prosecuting individual executives while not actually doing so, the DOJ reports that The Department of Health and Human Services’ Office of the Inspector General banned 3,340 individuals and entities from doing business with the federal government.

Here are the 16 worst-behaved drug and medical device companies in 2010, ranked by the size of the settlements or awards extracted by the DOJ:

1. Allergan, $600 million, mismarketing of Botox
2. AstraZeneca, $520 million, mismarketing of Seroquel
3. Novartis, $422.5 million, mismarketing of Trileptal and others
4. Forest Labs, $313 million, mismarketing of Lovothroid and Celexa
5. Mylan/UDL Labs/AZ and Johnson & Johnson, $124 million, underpaid rebates to Medicaid
6. Teva, $100 million, inflated prices
7. J&J, $81 million, mismarketing of Topamax
8. Novartis, $72.5 million, mismarketing of TOBI for cystic fibrosis
9. Alpharma, $42.5 million, mismarketing of Kadian
10. KV Pharmaceutical, $27.5 million, oversized pills
11. Biovail, $24.7 million, mismarketing of Cardizem
12. Boston Scientific, $22 million, kickbacks on defibrillators
13. Cardinal Health and Bindley Western, $5.5 million, overcharging the DOD
14. Spectranetics Corporation, $4.9 million, marketing unapproved medical devices
15. Atricure, $3.7 million, mismarketing surgical devices
16. Sandoz, $3.5 million, fraudulent reimbursement for nitroglycerin tablets

Rah Rah Rah!!
The Winner is Allergan!!!
 












Do you ever wonder what is going to happen when botox gets it's new approvals and our speakers go all the way off-label again? Guaranteed to win the same prize in 2012.
 












Anonymous said:
http://www.bnet.com/blog/drug-busin...the-worst-behaved-drug-companies-of-2010/7195

Rogues Gallery: DOJ Lists the Worst-Behaved Drug Companies of 2010
By Jim Edwards | January 25, 2011

Congratulations, Allergan (AGN): The company paid the biggest settlement to the Department of Justice’s healthcare fraud and abuse program in 2010, $600 million for the unapproved, “off-label” promotion of Botox for headaches. 2010 was a banner year for bad behavior in the drug business, according to the DOJ. There were:

o $2.5 billion in health care fraud judgments and settlements.
o 1,116 new criminal health care fraud investigations.
o 2,095 potential defendants in those cases.
o 1,787 ongoing criminal health care fraud investigations pending.
o 2,977 potential defendants in those cases.
o 488 cases with criminal charges filed.
o 931 actual defendants in those cases.
o 726 defendants convicted of health care fraud-related crimes

The statistic that managers ought to pay most attention to is the one describing them. While I’ve criticized the DOJ in the past for talking a lot about prosecuting individual executives while not actually doing so, the DOJ reports that The Department of Health and Human Services’ Office of the Inspector General banned 3,340 individuals and entities from doing business with the federal government.

Here are the 16 worst-behaved drug and medical device companies in 2010, ranked by the size of the settlements or awards extracted by the DOJ:

1. Allergan, $600 million, mismarketing of Botox
2. AstraZeneca, $520 million, mismarketing of Seroquel
3. Novartis, $422.5 million, mismarketing of Trileptal and others
4. Forest Labs, $313 million, mismarketing of Lovothroid and Celexa
5. Mylan/UDL Labs/AZ and Johnson & Johnson, $124 million, underpaid rebates to Medicaid
6. Teva, $100 million, inflated prices
7. J&J, $81 million, mismarketing of Topamax
8. Novartis, $72.5 million, mismarketing of TOBI for cystic fibrosis
9. Alpharma, $42.5 million, mismarketing of Kadian
10. KV Pharmaceutical, $27.5 million, oversized pills
11. Biovail, $24.7 million, mismarketing of Cardizem
12. Boston Scientific, $22 million, kickbacks on defibrillators
13. Cardinal Health and Bindley Western, $5.5 million, overcharging the DOD
14. Spectranetics Corporation, $4.9 million, marketing unapproved medical devices
15. Atricure, $3.7 million, mismarketing surgical devices
16. Sandoz, $3.5 million, fraudulent reimbursement for nitroglycerin tablets

Rah Rah Rah!!
The Winner is Allergan!!!
Click to expand...

Why don't you try putting this kind of effort into your pre-call planning and see what THAT gets you?

Suck it, douche.
 






My pre-planning is excellent. How come only certain people with a certain look and a certain level of psycophantic behavior get promoted at this company. The rest of us are sample droppers with no room for advancement or earning power.
 






























Does anyone know what is going on with the policeman pension fund from Texas that is currently suing Mike Ball, David Pyott and others for the 600 million dollars they cost the company for knowingly off label promoting Botox? If not, stay tuned. This is a pension fund looking to recoup their losses directly from the pockets of the corporate elite of Allergan by forcing the executives to pay out of their own pockets collectively to the company for their role in the fraud. So a windfall may be coming to Allergan employees when the case goes to court.
 






Anonymous said:
Does anyone know what is going on with the policeman pension fund from Texas that is currently suing Mike Ball, David Pyott and others for the 600 million dollars they cost the company for knowingly off label promoting Botox? If not, stay tuned. This is a pension fund looking to recoup their losses directly from the pockets of the corporate elite of Allergan by forcing the executives to pay out of their own pockets collectively to the company for their role in the fraud. So a windfall may be coming to Allergan employees when the case goes to court.
Click to expand...

Do you think this is why Mike ball left?
 


















Anonymous said:
Does anyone know what is going on with the policeman pension fund from Texas that is currently suing Mike Ball, David Pyott and others for the 600 million dollars they cost the company for knowingly off label promoting Botox? If not, stay tuned. This is a pension fund looking to recoup their losses directly from the pockets of the corporate elite of Allergan by forcing the executives to pay out of their own pockets collectively to the company for their role in the fraud. So a windfall may be coming to Allergan employees when the case goes to court.
Click to expand...

Yes. The case is collecting evidence against the Allergan elite. I suppose our own whistlelower AH is assisting the lawfirm in Texas putting blame where it belongs: Gangoli, Pyott and Ball.
 
























Top Bottom
Back
Quote